Old Web
English
Sign In
Acemap
>
authorDetail
>
Joseph Malachy Burke
Joseph Malachy Burke
University of Colorado Boulder
Medicine
Pathology
Erlotinib
Crizotinib
non-small cell lung cancer (NSCLC)
3
Papers
475
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Point-of-Care Algorithm to Guide Proper Selection of Ambulatory ECG Monitors.
2021
Critical pathways in cardiology
Morteza Farasat
José M. Sánchez
J. Jason West
Joseph Malachy Burke
Andrew F. Prouse
M. Odette Gore
Gerard Salame
Joseph Walker Keach
Stacey A. Trent
Mark C. Haigney
Shea E. Hogan
Pamela N. Peterson
Brian L. Stauffer
Matthew R. Holland
Mori J. Krantz
Show All
Source
Cite
Save
Citations (0)
Continuation of EGFR/ALK inhibition after local therapy of oligoprogressive disease in EGFR mutant (Mt) and ALK+ non-small cell lung cancer (NSCLC).
2017
Journal of Clinical Oncology
Andrew Weickhardt
Benjamin Scheier
Joseph Malachy Burke
Gregory Gan
Robert C. Doebele
Paul A. Bunn
Laurie E. Gaspar
Brian D. Kavanagh
D. Ross Camidge
Show All
Source
Cite
Save
Citations (17)
Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer
2012
Journal of Thoracic Oncology
Andrew Weickhardt
Benjamin Scheier
Joseph Malachy Burke
Gregory Gan
Xian Lu
Paul A. Bunn
Dara L. Aisner
Laurie E. Gaspar
Brian D. Kavanagh
Robert C. Doebele
D. Ross Camidge
Show All
Source
Cite
Save
Citations (458)
1